Silver nitrate cutaneous solution 2% w/w

Clear solution.

References: [1]

Caustic for targeted destruction of pathological tissue, such as warts, according to AEMPS.

References: [1]

Clear solution. Quantities/raw-material quality follow §3. No specific numerical finished-product assay limit is provided.

References: [1]

The finished preparation is stored protected from light under the monograph.

References: [1]

Silver nitrate: protect from air and organic contamination.

References: [4]

Silver nitrate is very soluble in water.

References: [4]

No specific finished-product information is established in the reviewed sources. Additional evidence is required before defining a specification.

References: [1]

Finished-product storage: Below 30°C; protect from light. Processing follows the method-specific temperatures.

References: [1]

No specific finished-product information is established in the reviewed sources. Additional evidence is required before defining a specification.

References: [1]

Silver nitrate: incompatible with alkalis, acids and halogen salts, phosphates and tannins.

References: [4]

Exact identities: Νιτρικός άργυρος / Silver nitrate; Κεκαθαρμένο ύδωρ / Purified water. Use pharmacopoeial raw materials of the referenced edition, with CoA verification. Do not arbitrarily change salt, hydration state or strength. Record the actual q.s. amount in the batch.

References: [1]

Laboratory environment under the referenced AEMPS procedure: 25±5°C and relative humidity ≤60%, unless the specific formulation requires otherwise. Room temperature differs from processing temperature.

References: [2]

Clean protective clothing and head covering under AEMPS PN/L/PG/002/00. Use suitable gloves where contact is possible and respiratory/eye protection where powder handling requires it. Exact glove material, ventilation and respiratory protection must follow the SDS and local exposure assessment.

References: [3]

Caustic; may cause permanent staining/argyria. Ingestion can cause severe toxicity. Prevent staff eye and skin contact.

References: [1]

The specific monograph states 2 weeks under its specified conditions. This is a source period, not independently verified stability of the local batch. Match composition, preservative, container and storage, check applicable requirements and obtain responsible approval. The actual date remains blank.

References: [1]

No separate compound base is required in the explicit formula.

References: [1]

Balance with suitable resolution, mortar/spatula, suitable mixing vessels and final container. Add volumetric equipment for mL, a controlled water bath where melting is specified and a suitable filter where required. Analytical equipment follows the QC methods.

References: [2]

1. Weigh 0.3 g silver nitrate and purified water.
2. Dissolve with continuous stirring.
3. Make up to a final mass of 15 g with water and mix. The formula is mass-based, not volume-based.

References: [1] · [2]

0.3 g/15 g = 2% w/w. This is not an ophthalmic preparation.

References: [1]

Nonmetallic, alkalinity-free, hermetically closed light-resistant container, e.g. amber glass.

References: [1]

Silver nitrate cutaneous solution 2% w/w
Quantity: _____ · Batch: _____ · Prepared: _____ · Use by: _____
External use only. Storage: Below 30°C; protect from light.
Patient/directions or laboratory use: _____ · Pharmacy/telephone: _____
Specimen for pharmacist adaptation; not a final approved label.

References: [1]

Under AEMPS: organoleptic properties and final mass and/or volume. For batches: colour RFE 2.2.2, clarity/opalescence RFE 2.2.1, relative density RFE 2.2.5, pH under PN/L/CP/001/00 and microbiological testing under RFE 5.1.4. This formula provides no numerical pH/density limits or specific active assay.

References: [1] · [2]

Below 30°C; protect from light.

References: [1]

External use only, targeted to the lesion. The source gives one application/day with a suitable applicator. Protect surrounding healthy skin; avoid eyes and mucosa. Children, pregnancy and breastfeeding require medical assessment.

References: [1]